Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Free Cash Flow (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Free Cash Flow for 16 consecutive years, with $4.2 million as the latest value for Q3 2025.

  • On a quarterly basis, Free Cash Flow rose 209.42% to $4.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was $5.2 million, a 129.93% increase, with the full-year FY2024 number at -$16.0 million, down 45.92% from a year prior.
  • Free Cash Flow was $4.2 million for Q3 2025 at Xtant Medical Holdings, up from $910000.0 in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $4.2 million in Q3 2025 to a low of -$6.5 million in Q1 2024.
  • A 5-year average of -$1.6 million and a median of -$1.5 million in 2022 define the central range for Free Cash Flow.
  • Peak YoY movement for Free Cash Flow: surged 947.52% in 2021, then tumbled 1245.32% in 2022.
  • Xtant Medical Holdings' Free Cash Flow stood at -$203000.0 in 2021, then crashed by 1245.32% to -$2.7 million in 2022, then soared by 53.2% to -$1.3 million in 2023, then soared by 99.45% to -$7000.0 in 2024, then surged by 59842.86% to $4.2 million in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Free Cash Flow are $4.2 million (Q3 2025), $910000.0 (Q2 2025), and $87000.0 (Q1 2025).